PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...
At the end of treatment-free intervals up to 80 days, patients with atopic dermatitis treated with tapinarof maintained low disease level.
In this video, Robert Sidbury MD, MPH, division head of dermatology at Seattle Children’s Hospital and professor in the department of pediatrics at University of Washington School of Medicine, ...
Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...
Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis ...
A Review of the Research Progress and Application of Skin Care Ointments in Chronic Eczema Treatment ...
Upadacitinib demonstrates early and sustained effectiveness up to 1 year in patients with moderate to severe atopic dermatitis in a real-world study.
The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback